Structures ofCryptococcus neoformansProtein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal Pathogens

Finding a Needle in the Haystack: Computational Modeling of Mg2+Binding in the Active Site of Protein Farnesyltransferase

(2010) Yue Yang et al.   BIOCHEMISTRY

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Interaction of Cryptococcus neoformans Rim101 and Protein Kinase A Regulates Capsule

(2010) Teresa R. O'Meara et al.   PLoS Pathogens

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Structural Basis for Binding and Selectivity of Antimalarial and Anticancer Ethylenediamine Inhibitors to Protein Farnesyltransferase

(2009) Michael A. Hast et al.   CHEMISTRY & BIOLOGY

Identification of Novel Peptide Substrates for Protein Farnesyltransferase Reveals Two Substrate Classes with Distinct Sequence Selectivities

(2009) James L. Hougland et al.   JOURNAL OF MOLECULAR BIOLOGY

Antibiotics for Emerging Pathogens

(2009) M. A. Fischbach et al.   SCIENCE

Capsule enlargement inCryptococcus neoformansconfers resistance to oxidative stress suggesting a mechanism for intracellular survival

(2008) Oscar Zaragoza et al.   CELLULAR MICROBIOLOGY

Caged Protein Prenyltransferase Substrates: Tools for Understanding Protein Prenylation

(2008) Amanda J. DeGraw et al.   Chemical Biology & Drug Design

Subcellular Localization Directs Signaling Specificity of theCryptococcus neoformansRas1 Protein

(2008) Connie B. Nichols et al.   EUKARYOTIC CELL